Chengfen Wang
Impact in
- Hepatology top 5%
- Liver physiology and pathology
- Liver Diseases and Immunity
- Liver Disease and Transplantation
- Biochemistry top 5%
- Sulfur Compounds in Biology
Papers in
- Epidemiology 13
- Liver Disease Diagnosis and Treatment 8
- Autophagy in Disease and Therapy 4
- Hepatitis B Virus Studies 3
-
- Heme Oxygenase-1 and Carbon Monoxide 3
- Co-authors
- Chuanyong Guo (21 shared papers)Kan Chen (19 shared papers)Weiqi Dai (18 shared papers)Miao Shen (16 shared papers)Jie Lu (16 shared papers)Jingjing Li (17 shared papers)Ping Cheng (15 shared papers)Ling Xu (12 shared papers)
- Journals
- PLoS ONE (3 papers)Biochemical and Biophysical Research Communications (2 papers)Molecular Carcinogenesis (1 paper)Hepatology Research (1 paper)Biomedicine & Pharmacotherapy (1 paper)
- Partner nations
- China
In The Last Decade
Chengfen Wang
21 papers receiving 953 citations
Peers
Comparison fields: 5 of 93
- Hepatology 247
- Biochemistry 85
- Pharmacology 92
- Clinical Biochemistry 71
- Epidemiology 339
Countries citing papers authored by Chengfen Wang
This map shows the geographic impact of Chengfen Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengfen Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengfen Wang more than expected).
Fields of papers citing papers by Chengfen Wang
This network shows the impact of papers produced by Chengfen Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengfen Wang. The network helps show where Chengfen Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Chengfen Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 101 | |
| 2 | 2014 | 92 | |
| 3 | 2013 | 76 | |
| 4 | 2013 | 76 | |
| 5 | 2014 | 58 | |
| 6 | 2014 | 57 | |
| 7 | 2019 | 56 | |
| 8 | 2013 | 55 | |
| 9 | 2014 | 48 | |
| 10 | 2017 | 38 | |
| 11 | 2018 | 38 | |
| 12 | 2014 | 38 | |
| 13 | 2014 | 36 | |
| 14 | 2014 | 32 | |
| 15 | 2018 | 30 | |
| 16 | 2014 | 28 | |
| 17 | 2015 | 26 | |
| 18 | 2015 | 23 | |
| 19 | 2014 | 22 | |
| 20 | 2013 | 21 |
About Chengfen Wang
Chengfen Wang is a scholar working on Epidemiology, Molecular Biology, Hepatology, Cancer Research and Surgery, having authored 21 papers that have together received 961 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (8 papers), Autophagy in Disease and Therapy (4 papers), Liver physiology and pathology (3 papers), Hepatitis B Virus Studies (3 papers), Advanced Glycation End Products research (3 papers), Heme Oxygenase-1 and Carbon Monoxide (3 papers), Drug-Induced Hepatotoxicity and Protection (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). The work is most often cited by research in Hepatology (247 citations), Biochemistry (85 citations), Pharmacology (92 citations), Clinical Biochemistry (71 citations) and Epidemiology (339 citations). Chengfen Wang has collaborated with scholars based in China. Frequent co-authors include Chuanyong Guo, Kan Chen, Weiqi Dai, Miao Shen, Jie Lu, Jingjing Li, Ping Cheng, Ling Xu, Fan Wang and Yingqun Zhou. Their work appears in journals such as PLoS ONE, Biochemical and Biophysical Research Communications, Molecular Carcinogenesis, Hepatology Research and Biomedicine & Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.